A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner

The current COVID-19 pandemic has highlighted the urgent need to develop effective therapeutic strategies. We evaluated the in vitro antiviral effect against SARS-CoV-2 of a hepatitis B virus (HBV) hexamer peptide, Poly6, which is capable of eliciting an antiviral effect against human immunodeficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yu-Min, Jeong, Hyein, Park, Uni, Cho, Nam-Hyuk, Kim, Bum-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310041/
https://www.ncbi.nlm.nih.gov/pubmed/34202029
http://dx.doi.org/10.3390/v13071227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310041/
https://www.ncbi.nlm.nih.gov/pubmed/34202029
http://dx.doi.org/10.3390/v13071227

Ejemplares similares